Skip to main content
  • En
  • Français

Top Navigation

  • Newsroom
  • Contact Us

Main navigation

  • About Us
  • Products
  • Technology
  • Clinical Studies
  • Investors
  • News
  • En
  • Français

2018

Bone Therapeutics: Information on the total number of voting rights and shares (October 2018)

  • Read more about Bone Therapeutics: Information on the total number of voting rights and shares (October 2018)

Bone Therapeutics announces appointment of Linda Lebon as Chief Regulatory Officer

  • Read more about Bone Therapeutics announces appointment of Linda Lebon as Chief Regulatory Officer

Bone Therapeutics announces conclusions from interim analysis of Phase III PREOB study in hip osteonecrosis

  • Read more about Bone Therapeutics announces conclusions from interim analysis of Phase III PREOB study in hip osteonecrosis

Bone Therapeutics Business Update for Third Quarter 2018

  • Read more about Bone Therapeutics Business Update for Third Quarter 2018

Bone Therapeutics: Information on the total number of voting rights and shares (November 2018)

  • Read more about Bone Therapeutics: Information on the total number of voting rights and shares (November 2018)

Bone Therapeutics: Transparency notification received from S.R.I.W. SA and Sofipôle SA

  • Read more about Bone Therapeutics: Transparency notification received from S.R.I.W. SA and Sofipôle SA

Bone Therapeutics: Information on the total number of voting rights and shares (December 2018)

  • Read more about Bone Therapeutics: Information on the total number of voting rights and shares (December 2018)

Bone Therapeutics announces half-year results for 2018

  • Read more about Bone Therapeutics announces half-year results for 2018

Bone Therapeutics Business Update for the Third Quarter of 2018

  • Read more about Bone Therapeutics Business Update for the Third Quarter of 2018

Pagination

  • Previous page ‹‹
Subscribe to 2018
Wallonie Eu Flag

BioSenic SA
Rue Granbonpré 11 – Bâtiment H (bte 24)
1435 Mont-St-Guibert – Belgium
T.: +32 493 09 73 66
info@biosenic.com
Contact

Sign upfor our press releases

Receive information about BioSenic

Sign Up

Footer menu

  • Privacy Policy
  • Trademarks Copyrights
  • Users conditions